(2) DJ EQS-News: Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Index-es Including the Hang Seng Composite Index EQS-News / 01/03/2021 / 15:36 UTC+8 Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index Shanghai and Hong Kong, PRC, March 1, 2021 Antengene Corporation Limited ( Antengene , SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and /or best-in-class therapeutics in hematology and oncology, today announced that the company has been selected as a constituent stock of the Hang Seng Composite Index (HSCI), the Hang Seng Stock Connect Hong Kong Index (HSHKI), the Hang Seng Stock Connect Hong Kong MidCap & SmallCap Index (HSHKMS), the Hang Seng Stock Connect Hong Kong SmallCap Index (HSHKS), the Hang Seng SCHK Mainland China Companies Index (HSSCMLC), the Hang Seng SCHK e
Antengene (6996 HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Search jobs Ascentage Pharma Officially Included in Shenzhen-Hong Kong Stock Connect Program
SUZHOU, China and ROCKVILLE, Md., Dec. 30, 2020 /PRNewswire/ Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company was officially included into the Shenzhen-Hong Kong Stock Connect program (the Hong Kong Stock Connect ). This was officially announced by the Shenzhen Stock Exchange ( SZSE ) on December 25, 2020, which has been effective since December 28, 2020. This inclusion is the very first arrangement for the eligible pre-revenue biotech companies listed under Chapter 18A of Hong Kong s Main Board Listing Rules, and complied with the conditions for the inclusion in the Hong Kong Stock Connect.
China Risun Acquisition of Six Hongye Chemicals Enterprises Approved at EGM – IT Business Net itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
China Risun Acquisition of Six Hongye Chemicals Enterprises Approved at EGM
Further Leverages the Economics of Scale, Resources and Cost Advantages of these Acquisitions to Strengthen the Leading Position in the Market
HONG KONG, Dec 23, 2020 - (ACN Newswire) - China Risun Group Limited ( China Risun , or the Group , stock code: 1907), the global leading integrated coke, coking chemical and refined chemical producer and supplier in China, held an Extraordinary General Meeting in Hong Kong and obtained the approval of the acquisition of six Hongye Chemical Enterprises for RMB4.85 billion. Upon completion, the Group can further leverage the economics of scale, resources and cost advantages of these acquisitions to strengthen its leading position in the market.